(Q52235990)
Statements
A design alternative for two-stage, phase II, multicenter cancer clinical trials. (English)
1 reference
Herndon JE 2nd
1 reference
1 October 1998
1 reference
19
1 reference
5
1 reference
440-450
1 reference